 |
Interferon alfa-2a (recombinant) |
|---|---|
| Trade Name | Roferon-A |
| Orphan Indication | For the concomitant administration with fluorouracil for the treatment of advanced colorectal cancer |
| USA Market Approval | USA |
| USA Designation Date | 1990-05-14 00:00:00 |
| Sponsor | Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07110 |
